APRE swing ideaStrong support here and daily CBD formed, potential on weekly CBD RSI and MACD. Potential 4h triple CBD and 1h CBD forming. Seems strong for a push up, could push more above 3.2.
0%
0%
0%
0%
0%
−22.93USD
−112.662MUSD
3.737M
About Aprea Therapeutics, Inc.
Sector
CEO
Oren Gilad
Headquarters
Doylestown
Website
Employees
9
Founded
2002
ISIN
US03836J2015
Aprea Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the provision of cancer therapeutics. It is involved in the development and commercialization of novel cancer therapeutics that reactivate mutant p53 tumor suppressor protein. The company was founded by Vladimir Bykov, Klas Gota Wiman, Staffan Stromblad, Natalia Issaeva, Galina Selivanova, and Wen Jie Bao in 2002 and is headquartered in Doylestown, PA.
$APRE looking perky $APRE big catalysts within the next 2 weeks. Moves fast on news and major gap to fill.
$APRE next small cap pop!!!! From a technical standpoint we are looking pretty strong as we closed about the 9-day AND the 26-day moving average with high buying pressure whicks which is interesting
Now from a company perspective standpoint we are most likely to first get approval on, this would be like the most expens
MARKET ALPHA OPTIONS WATCHLIST - APRENASDAQ:APRE
Very unusual options activity came in on this one at 4.79 with the assumption the stock would continue higher by August 8th.
Currently the option play is down but that doesn't mean we haven't found support here and may bounce higher catching some off guard. If not the support level is
APREAprea Therapeutics Inc (NASDAQ:APRE) Potential breakout play. Watch the stock closely tomorrow and once it breaks $5.75, get ready to jump in and buy the stock for another swing trade. Stop 5.1
deep cupgoal is to accumulate 800 to 1.5K shares in this thing until we see some major gap fills. Currently sitting on 150 shares, watching it daily. The Street just left it for dead, liking this $5 handle for accum, no stops, buy weakness, just let the pro shorts in this cover and let the chase begin on th
APREOnly way I would want to play this stock is if it broke over the $8.4 resistance area and proved that it could have a gap fill potential (likely would not actually fill this gap but should be able to run a bit more). What I’m not loving about this ticker is the news was ultra fluffy AND there’s a lo
6/6 wins with a few more called out for good luck +$2233.00Hi Guys,
Took a lot of trades today. Whohoo!!!
Thanks,
Enda
APRE longnot much to describe here.
I will just give it a try with a tight stop-loss.
expecting it to fill the gap.
the drop back in dec happened because one of its clinical trials did not succeed.
but they still work on others.
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
